PharmaCyte Biotech Inc (PMCB)

[BioNewton]

Before a decision is made about whether something works or doesn't it's probably important to understand clinical trials and what they are for.

That's how medical companies find out if their product works. It's the only way. The only one that can say this works or doesn't, is Ciab itself. I'm just happy that PMCB is doing everything the right way to insure CiaB stands a chance of performing. That's all we can ask.

The rest is speculation here (and not by doctors) and really doesn't matter in the end on either side. Just as the pps doesn't matter because once a partner swoops in, it won't matter is we are at .05 or .65 at the time, the partner will decide what its worth in the buyout.